Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,083.81 891.73 226.99 -107.48 41.41 0.03 15.1970 -0.37 -117.4235 -2,432.7664 -9.36 -8.97 781.8125 - -
Maximum - - - - - - 593,913.00 65,349.00 25,407.00 99,050.00 5,305.00 0.94 1,336.3467 6.70 300.5100 8,534.8500 38.40 835.37 6,156.2100 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -10,177.5800 -144,478.0000 -155.91 -1,263.79 0.0700 - -
Halozyme Therapeutics, Inc. HALO 60.65 -1.66 -2.66% 410 vs. 1,295 7,683.00 195.00 76.00 125.00 167.00 0.6100 17.0691 0.00 76.47 39.22 43.21 4.17 500.88 126.00
Insmed Incorporated INSM 75.23 2.36 3.24% 237 vs. 2,280 12,928.00 75.00 -157.00 -188.00 -3,603.00 -1.0600 -6.3128 0.00 75.21 -208.07 33.80 -13.55 150.38 171.00
Karuna Therapeutics, Inc. KRTX 329.83 0.09 0.03% 1,283 vs. 971 12,599.00 0.00 -113.00 -111.00 -997.00 -3.0100 -26.2644 0.00 0.00 0.00 -9.08 -8.52 1860.75 38.00
Cerevel Therapeutics Holdings, Inc. CERE 44.96 0.33 0.74% 15,033 vs. 2,056 8,191.00 0.00 -131.00 -119.00 -1,532.00 -0.7300 -14.5661 0.00 0.00 0.00 -23.37 -11.70 1012.15 182.00
DICE Therapeutics, Inc. DICE 47.55 0.03 0.06% 4,332 vs. 1,753 2,270.00 0.00 -34.00 -30.00 -248.00 -0.7400 -15.7831 0.00 0.00 0.00 -6.71 -6.32 2568.58 47.00
Cytokinetics, Incorporated CYTK 53.90 -2.04 -3.65% 715 vs. 1,406 6,341.00 0.00 -135.00 -127.00 -2,247.00 -1.3300 -13.7171 0.00 -179.16 -16244.67 34.24 -16.79 697.96 117.00
Corcept Therapeutics Incorporated CORT 43.02 0.75 1.76% 158 vs. 862 4,494.00 146.00 27.00 23.00 430.00 0.2700 23.8261 0.00 98.27 18.91 5.07 4.23 487.93 104.00
Ultragenyx Pharmaceutical Inc. RARE 59.10 1.40 2.43% 19 vs. 782 5,446.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.00 75.76 -156.83 -121.69 -13.06 211.27 92.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for CORT and its peers to uncover potential buy and sell opportunities.